Spyder ETF declines before NYSE opening bell.
European Indexes are in positive side
SPY (intraday chart) downtrend at extended hours. Resistance: 176.30 , Support: 175.40
Pre-market NYSE/NASDAQ:
Gapping up:
• In reaction to strong earnings/guidance: BIIB +3.9%, CHA +2.9%, (light volume), AMX +1.3%, L +1.2%, (light volume).
• M&A news: DNDN +16.2% (reports out Friday indicate seeking takeover offers).
• Select solar related names showing strength: SCTY +3.4% (reinstated with an Outperform at Credit Suisse), JKS +3%, YGE +2.1%, LDK +2%, JASO +1.7%, SUNE +1.1%.
• Select metals/mining stocks trading higher: SLW +0.9%, ABX +0.8%, IAG +0.8%.
• Other news: ZGNX +21.7% ( confirms FDA approval for Zohydro ER Extended-Release Capsules), NQ +5.4% (modestly rebounding), PBR +4.5% (still checking), DARA +3% (Announces Sales Force Expansion and Agreement With Mission Pharmacal in the Oncology Market), CF +2.8% and MOS +2.3% ( The Mosaic Company (MOS) to acquire Florida phosphate business from CF Industries for $1.2 bln), FIO +2.7% (still checking), BMY +2.7% ( presents efficacy and safety data from Phase IIb dose-ranging study of subcutaneous clazakizumab; all arms met the primary endpoint; upgraded to Overweight from Equal Weight at Morgan Stanley ), PT +2.4% (still checking), ARIA +1.7% (still checking), TSLA +1.5% (wants to sell 10K cars in Germany by 2015, CEO says, according to reports), AMX +1.3% ( Carlos Slim Helú discloses 15.8% active stake in amended 13D filing out Friday after the close; up from 15.2 % reported on 8/8), FRM +1.1% (ticking higher on positive Barron's mention ), BT +0.9% (still checking).
• Analyst comments: AZN +1.2% (upgraded to Neutral from Underperform at BofA/Merrill),
Gapping down:
• In reaction to disappointing earnings/guidance: CYOU -18%, SOHU -8.8%, BWP -2.4% (light volume), RNF -2.4% (light volume), BRFS -1.9%, MRK -1.7%, ROP -1.5%, ILMN -1.4%, ( signed a definitive agreement to acquire Santa Clara-based NextBio; terms not dislcosed; reaffirms FY13 guidance).
• Select financial related names showing weakness: BCS -2.3%, SAN -1.2%, DB -1%.
• Other news: CNX -3.8% ( takes transformative step to advance E&P Growth Strategy - sells Consolidation Coal Company (5 WV mines, related assets) for $3.5 bln; deal delevers CNX and and advances gas growth production strategy; cuts dividend 50%), TEVA -1.7% (Teva Pharma early weakness may be attributed to speculation related to CEO departure).
Analyst comments: CROX -4.2% (downgraded to Neutral from Overweight at Piper Jaffray), RIG -1% (downgraded to Sell from Neutral at Goldman), ARMH -0.9% (downgraded to Hold at The Benchmark Company), BIDU -0.9% (downgraded to Hold from Buy at Exane BNP Paribas), BA -0.3% (downgraded to Neutral from Buy at Buckingham Research)
Earnings stocks:
Today before market open: ARLP AWI BIIB BKW BOH BWP CNA CYOU DCOM EDR EW HAE KEX L MCY ONB ROP SBCF SOHU STNG TEN TGE TRS UFPT
Trading Ideas NYSE & NASDAQ:
• DNDN – long above premarket high
• SCTY – long above 60.00
• SOHU – short below premarket low
Original: NYSE Analytics 28 October - Shark Traders
European Indexes are in positive side
SPY (intraday chart) downtrend at extended hours. Resistance: 176.30 , Support: 175.40
Pre-market NYSE/NASDAQ:
Gapping up:
• In reaction to strong earnings/guidance: BIIB +3.9%, CHA +2.9%, (light volume), AMX +1.3%, L +1.2%, (light volume).
• M&A news: DNDN +16.2% (reports out Friday indicate seeking takeover offers).
• Select solar related names showing strength: SCTY +3.4% (reinstated with an Outperform at Credit Suisse), JKS +3%, YGE +2.1%, LDK +2%, JASO +1.7%, SUNE +1.1%.
• Select metals/mining stocks trading higher: SLW +0.9%, ABX +0.8%, IAG +0.8%.
• Other news: ZGNX +21.7% ( confirms FDA approval for Zohydro ER Extended-Release Capsules), NQ +5.4% (modestly rebounding), PBR +4.5% (still checking), DARA +3% (Announces Sales Force Expansion and Agreement With Mission Pharmacal in the Oncology Market), CF +2.8% and MOS +2.3% ( The Mosaic Company (MOS) to acquire Florida phosphate business from CF Industries for $1.2 bln), FIO +2.7% (still checking), BMY +2.7% ( presents efficacy and safety data from Phase IIb dose-ranging study of subcutaneous clazakizumab; all arms met the primary endpoint; upgraded to Overweight from Equal Weight at Morgan Stanley ), PT +2.4% (still checking), ARIA +1.7% (still checking), TSLA +1.5% (wants to sell 10K cars in Germany by 2015, CEO says, according to reports), AMX +1.3% ( Carlos Slim Helú discloses 15.8% active stake in amended 13D filing out Friday after the close; up from 15.2 % reported on 8/8), FRM +1.1% (ticking higher on positive Barron's mention ), BT +0.9% (still checking).
• Analyst comments: AZN +1.2% (upgraded to Neutral from Underperform at BofA/Merrill),
Gapping down:
• In reaction to disappointing earnings/guidance: CYOU -18%, SOHU -8.8%, BWP -2.4% (light volume), RNF -2.4% (light volume), BRFS -1.9%, MRK -1.7%, ROP -1.5%, ILMN -1.4%, ( signed a definitive agreement to acquire Santa Clara-based NextBio; terms not dislcosed; reaffirms FY13 guidance).
• Select financial related names showing weakness: BCS -2.3%, SAN -1.2%, DB -1%.
• Other news: CNX -3.8% ( takes transformative step to advance E&P Growth Strategy - sells Consolidation Coal Company (5 WV mines, related assets) for $3.5 bln; deal delevers CNX and and advances gas growth production strategy; cuts dividend 50%), TEVA -1.7% (Teva Pharma early weakness may be attributed to speculation related to CEO departure).
Analyst comments: CROX -4.2% (downgraded to Neutral from Overweight at Piper Jaffray), RIG -1% (downgraded to Sell from Neutral at Goldman), ARMH -0.9% (downgraded to Hold at The Benchmark Company), BIDU -0.9% (downgraded to Hold from Buy at Exane BNP Paribas), BA -0.3% (downgraded to Neutral from Buy at Buckingham Research)
Earnings stocks:
Today before market open: ARLP AWI BIIB BKW BOH BWP CNA CYOU DCOM EDR EW HAE KEX L MCY ONB ROP SBCF SOHU STNG TEN TGE TRS UFPT
Trading Ideas NYSE & NASDAQ:
• DNDN – long above premarket high
• SCTY – long above 60.00
• SOHU – short below premarket low
Original: NYSE Analytics 28 October - Shark Traders
